BioSpace News Archive

Press Releases

RESTEM Receives FDA Orphan Drug Designation for its ULSC Program for the Treatment of Polymyositis and Dermatomyositis

December 4, 2024
·
3 min read
Press Releases

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 3, 2024

December 4, 2024
·
1 min read
Press Releases

Congruence and Ono Announce Multi-Target Research Collaboration to Generate Small Molecule Correctors for the Treatment of Cancer

December 4, 2024
·
3 min read
Press Releases

Spur Therapeutics Announces Development Candidate in Parkinson’s Disease Gene Therapy Program

December 4, 2024
·
5 min read
Press Releases

Kraig Biocraft Laboratories Announces Investor Web Conference Highlighting Commercialization Progress of Spider Silk Technologies

December 4, 2024
·
2 min read
Press Releases

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

December 4, 2024
·
3 min read
Press Releases

Diagonal Therapeutics to Present Data at ASH 2024 Demonstrating the Economic and Clinical Burden of Hereditary Hemorrhagic Telangiectasia (HHT)

December 4, 2024
·
4 min read
Press Releases

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

December 4, 2024
·
8 min read
Press Releases

Neuron23 Announces First-in-human Dose in Phase 1 Clinical Trial of NEU-111, a TYK2 Inhibitor with Best-in-class Potential for Immune-mediated Inflammatory Disorders

December 4, 2024
·
2 min read
Press Releases

Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to include Children as Young as 2 Years Old

December 4, 2024
·
10 min read